Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,737,655 papers from all fields of science
Search
Sign In
Create Free Account
zotarolimus
Known as:
zotarilumus
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Narrower (1)
ABT-578
Broader (1)
Sirolimus
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Successful retrieval of a dislodged Zotarolimus-eluting coronary stent in the ascending aorta
A. Udupa
2018
Corpus ID: 57602848
Coronary stent dislodgment or embolization is rare in the era of 3rd generation Drug Eluting Stents but is a challenging…
Expand
2018
2018
Safety and efficacy of zotarolimus‐eluting stents in the treatment of diabetic coronary lesions in Chinese patients: The RESOLUTE‐DIABETES CHINA Study
Zhengbin Zhu
,
Yongjian Wu
,
+30 authors
Ruiyan Zhang
Journal of Diabetes
2018
Corpus ID: 51895043
The RESOLUTE‐DIABETES CHINA study was specifically designed to investigate the safety and efficacy of Resolute zotarolimus…
Expand
2013
2013
Endothelial vasomotor function after everolimus-eluting stent implantation
S. Homs
,
G. Roura
,
+6 authors
Á. Cequier
2013
Corpus ID: 75547106
Background and aim: Several studies have reported some grade of endothelial dysfunction (ED) after sirolimus-eluting stent…
Expand
2010
2010
ENDOTHELIAL DYSFUNCTION AFTER DRUG-ELUTING STENT IMPLANTATION
R. Tudor
,
L. Petrescu
,
D. Maximov
2010
Corpus ID: 37771360
Introduction: Percutaneous transluminal coronary angioplasty with stent implantation is a very efficient method of…
Expand
2010
2010
Gateways to clinical trials.
A. Tomillero
,
M. A. Moral
Methods and Findings in Experimental and Clinical…
2010
Corpus ID: 21484227
Alemtuzumab, Atomoxetine hydrochloride; BioMatrix Flex drug-eluting stent, Botulinum toxin type B, Brivaracetam, Cannabidiol…
Expand
2008
2008
Randomized , Controlled , Multicenter Trial to valuate the Safety and Efficacy of Zotarolimus-ersus Paclitaxel-Eluting Stents in De Novo cclusive Lesions in Coronary Arteries
C. Mario
,
F. Neumann
,
+9 authors
L. Schwartz
2008
Corpus ID: 38488984
esults After 9 months, late lumen loss was significantly greater in the ZoMaxx group (in-stent 0.67 .57 mm vs. 0.45 0.48 mm; p 0…
Expand
2007
2007
Asociación entre la concentración plasmática de proteína C reactiva y el volumen de hiperplasia neointimal en pacientes tratados con implante de stent liberador de zotarolimus. Análisis volumétrico…
Leandro Lasave
,
Alex Abizaid
,
+11 authors
J. E. Sousa
2007
Corpus ID: 59080721
Introduction and objectives. C-reactive protein (CRP) is an inflammatory marker that predicts cardiac events in patients with…
Expand
2007
2007
Subacute Thrombotic Occlusion and Spontaneous Recanalization of the Right Coronary Artery After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Visualized by Coronary…
R. Wessely
,
René M. Botnar
,
M. Vorpahl
,
M. Schwaiger
,
A. Schömig
,
T. Ibrahim
Circulation
2007
Corpus ID: 71404288
A 58-year-old male was admitted to the emergency room with an acute inferior ST-elevation myocardial infarction (Figure 1). His…
Expand
2006
2006
omparison of Zotarolimus-Eluting nd Sirolimus-Eluting Stents in Patients ith Native Coronary Artery Disease Randomized Controlled Trial avid
E. Kandzari
,
M. Leon
,
+12 authors
R. Kuntz
2006
Corpus ID: 52515337
avid E. Kandzari, MD, FACC,* Martin B. Leon, MD, FACC,‡ Jeffrey J. Popma, MD, FACC,§ eter J. Fitzgerald, MD, FACC, Charles O…
Expand
2006
2006
SPIRIT-II
Herz Kardiovaskuläre Erkrankungen
2006
Corpus ID: 263999264
Hintergrund und Problemstellung:Medikamente freisetzende Stents (DES) sind heute fester Bestandteil der Koronarinterventionen…
Expand